Navigation Links
New approach to anti-anxiety drugs

Researchers have found that lack of a brain protein makes mice notably less anxious and may extend the findings to humans with anxiety disorders. Anxiety is a natural human response to life,// but when it gets out of hand it can inhibit everyday behaviour and cause much suffering. Around 15 million people might have had the necessity for anxiety related treatment. The anti-anxiety drugs have always been very effective in such needy times. The major class is known as the benzodiazepines but these have the drawback of causing sedation that may make it hard to function. They also have the potential to cause addiction. Researchers at the University of North Carolina, and others, now report that they have found a potential new target for anti-anxiety drugs.

They've been looking at mice genetically altered so they don't produce a natural brain protein called protein kinase C. These mice seem to be more sensitive to the brain's own sedative molecules, known as neurosteroids. They are less fearful of heights and open spaces (a test of anxiety in mice). The researchers wonder if creating inhibitors for protein kinase C would be a useful way forward for treating anxiety in humans, providing an alternative to the benzodiazepines.


'"/>




Page: 1

Related medicine news :

1. Fresh approach to TB treatment
2. More signs to an approaching migraine attack
3. Gene enchances radiation therapy - A novel approach to fight cancer
4. Combined modality approach for effective treatment and enhanced survival in bile duct cancer
5. A new approach to vaginal hysterectomy
6. Multi targeted approach required for suicide prevention in adolescents
7. Mathematical approach to asthma
8. Trident approach reduces malaria in HIV patients
9. A Novel approach in Malaria treatment
10. Cancer drugs in development nearly doubled since 1995
11. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology: